There is a potential new class of senolytics that can remove or mitigate the effects of cellular senescence, a stress response which drives many age-related diseases. Publishing in iScience, researchers show the endogenous metabolite 25-hydroxycholesteral (25HC) significantly reduced the burden of senescent cells in multiple cell types in both mice and human cell culture, and in live mice, where it showed particular efficacy in skeletal muscle.
“Given that 25HC shares no common molecular motifs with other senolytics, it appears that this molecule represents a brand new class of potential interventions,” said a senior scientist on the study. “It’s most likely going to be useful in multiple contexts of senescence in different disease states, as well as in aging. We’re continuing to refine this molecule and its target, in order to understand how it works in the mouse and human cell types.”
The author said 25HC is a little understood oxidized lipid involved in cholesterol metabolism. The team identified it after discovering that the molecule disrupted cellular senescence in CRYAB, a small heat shock protein which was upregulated upon senescence in nine different cell types from two species, mice and humans. Diseases associated with CRYAB include myopathies, diseases that affect muscles that control voluntary movement in the body.
“Given the link between muscle loss, sarcopenia and human frailty we are focusing a lot of attention on skeletal muscle in my lab,” said the author. Working in mouse and human cell cultures researchers isolated specific cell types from skeletal muscle, made them senescent and showed that 25HC could kill them selectively. The team then went on to test 25HC in aged mice; experiments showed 25HC improved their muscle mass. Researchers also determined that 25HC killed senescent cells in mouse dermal fibroblasts, and in primary human cells from the lung, heart, liver, kidney and articular cartilage. “We are intending to use this molecule in multiple paradigms of aging and we’re hoping that other researchers will start testing it as well.”
The author said researchers also used a non-invasive biomarker (15d-PGJ2) developed in the the lab to validate their results in mice. The biomarker shows up in urine and was significantly increased in aged animals treated with 25HC. “This is a really important breakthrough for evaluating the efficacy of candidate senolytic drugs in vivo,” the author said. “Otherwise, how do you know whether the intervention is having any effect unless you’ve got some massive effect on functional outcomes? In aging research we don’t often have massive improvements when it comes to function, but even small effects can be beneficial.”
The author said 25HC would not have been discovered without the use of single cell sequencing, which provides a higher resolution in characterizing differences between individual cells, and a better understanding of single cells in the context of their microenvironment. “Senescent cells arise in only a small fraction of cells within a tissue as we age, and do not occur in all cells within an organ or tissue type,” said the author. “But because these cells are misbehaving through production of inflammatory factors, they’re having an impact on the surrounding tissue in a way which we can measure with this technology. Measuring that impact is particularly important, not to mention the fact that we can actually identify, characterize, and quantify such cells within the tissue itself.”
According to the author, 25HC has been found to increase in people infected with the SARS-CoV-2 virus, saying it may be some sort of defense mechanism against certain types of insult with viral infection being among them. “In fact, it’s been advocated to be a type of therapeutic for COVID infection. And there’s been two or three studies on this, showing that the molecule seems to be effective in reducing viral load,” the author said. “It’s not quite clear what’s going on with it, but there are some intriguing hints that it might be related to the burden of senescent cells as well.”
https://www.cell.com/iscience/fulltext/S2589-0042(22)00118-3
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fsenolysis-induced-by-25&filter=22
A potent naturally-occurring senolytic identified!
- 1,149 views
- Added
Latest News
Pan-cancer proteogenomics e…
By newseditor
Posted 05 Jul
Fertility treatments could…
By newseditor
Posted 05 Jul
Extended-release ketamine t…
By newseditor
Posted 05 Jul
How an unstructured protein…
By newseditor
Posted 04 Jul
Precise control of endogeno…
By newseditor
Posted 04 Jul
Other Top Stories
Phase separation drives aberrant chromatin looping and cancer devel…
Read more
Novel lncRNA counteracts heart failure progression
Read more
Fatigue, cognitive symptoms persist 6 months after covid-19 in ha…
Read more
How inhibitory neurons increase information transmission
Read more
The adhesions that build the brain's networks identified!
Read more
Protocols
Pan-cancer proteogenomics c…
By newseditor
Posted 05 Jul
A systems biology-based ide…
By newseditor
Posted 05 Jul
Tongue orthotopic xenograft…
By newseditor
Posted 04 Jul
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Publications
Prevention of Falls in Olde…
By newseditor
Posted 05 Jul
The primitive endoderm supp…
By newseditor
Posted 05 Jul
Migrasome biogenesis: when…
By newseditor
Posted 05 Jul
Extended-release ketamine t…
By newseditor
Posted 05 Jul
Regulation of stress-induce…
By newseditor
Posted 04 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar